Advisory Board and Editors Translational Medicine
Christopher Cooper
Senior Lecturer in Biological Sciences at the University of Huddersfield, since 2015. Previously Junior Research Fellow, College Lecturer In Biochemistry and various postdocs at the University of Oxford (2013-15). Working on DNA replication, genome integrity and transcription factors in human cancers (and also in prokaryotes). Additional interests in phylogenomics and novel protein expression systems.
Emanuela Felley-Bosco
Graduated in toxicology at the University of Lausanne, then trained at the Occupational Health Science Institute and at the Swiss Experimental Cancer Institute, and at the National Cancer Institute, USA. Main interest is cancer-related inflammation with special focus on mesothelioma. Principal investigator of translational research projects for the treatment of patients with mesothelioma, and non-clinical studies, which aim at a better understanding of the biology of mesothelioma development.
Carla Fiorentini
CARLA FIORENTINI is presently Director of Preclinical Research at the Association for Research of Integrative Oncology Therapies (ARTOI). She was Director of “Natural Substances, Traditional Medicine” Section at the Dept. of Therapeutic Research and Medicines Evaluation, and Coordinator of a Research Group at the Italian Center for Global Health, Istituto Superiore di Sanità (ISS), Roma. Academic Degree in Biology and Specialty in Microbiology, University of Roma. Post-doctoral training at Karolinska Institutet, Stockholm, Sweden. Her current research is focused on unravelling the role of bacterial protein toxins in cancer and on the use the bacterial toxin CNF1 as a potential novel therapeutic for central nervous system disorders. She is co-inventor in five different patents on CNF1 activity on the central nervous system. As co-author of numerous book chapters and articles in leading journals, she is renowned in the field of bacterial protein toxins.
Mario Alberto Flores-Valdez
Dr. Mario Alberto Flores-Valdez is a Professor in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., Guadalajara, Jalisco, Mexico (2007-present). He is a member of the National System of Researchers (SNI), and a member of the Mexican Academy of Sciences. He was a Stanford University Medical Center postdoctoral fellow (2004-2007), where he received a Dean's Fellowship Award (2006) to conduct research on Tuberculosis. He worked in UNAM as Research Assistant for Prof. Jaime Mora (2004) and Prof. Emundo Calva (2003). He has received a Ph.D. in Biochemistry from UNAM (1999-2003), a M.Sc. in Molecular Biology and Genetic Engineering from UANL (1996-1999) and a B.Sc. from Universidad de Sonora (1991-1996) in Chemistry and Biology. He received fellowships from CONACYT for M.Sc. and Ph.D. studies and in M.Sc. and B.Sc. has received Diplomas as Best Student. He has expertise in Tuberculosis, particularly in developing recombinant BCG strains. He has been PI for 7 grants from 2008 to date, focused in studies about tuberculosis vaccine development and basic aspects of mycobacterial physiology.
Uta Francke
Uta Francke is Professor of Genetics and Pediatrics, Emeritus, Stanford University School of Medicine. Past President, American Society of Human Genetics; Past President, International Federation of Human Genetics Societies; March of Dimes/Colonel Harland Sanders Lifetime Achievement Award in Genetics. Recipient of the William Allan Award of the American Society of Human Genetics. Senior Medical Director, 23andMe, Inc.
Robert Fruscio
Associate Professor of Obstetrics and Gynecology of the University of Milan-Bicocca, in Monza, Italy and staff physician in the general Gynecological Unit of San Gerardo Hospital. Before MD graduation and during the residency in Obstetrics and Gynecology he conducted an intense preclinical research activity at Mario Negri Institute (Milan) and at Massachusetts General Hospital (Boston). In 2010 he acquired a PhD in Gynecologic Oncology. His research interests are focused on molecular biology of ovarian cancer, and on prevention and treatment of gynecological malignancies.
2001: Degree in Medicine and Surgery
2006: Specialization in Obstetrics and Gynecology
2010: PhD in Gynecologic Oncology
2014: Associate Professor in Obstetrics and Gynecology
Kazumichi Fujioka
I received my medical degree from Kobe University in 2004. I completed my internship at Hyogo Prefectural Awaji Hospital, my pediatric residency at Kakogawa Municipal Hospital, and my fellowship in Neonatal-Perinatal Medicine at Kobe University Hospital and Kobe Children’s Hospital.
In parallel with my clinical training, I also received basic research training with a focus on the pathophysiology of neonatal diseases, first as a Postgraduate student at Kobe University, and then as a Postdoctoral scholar in the Dept of Pediatrics at Stanford University School of Medicine.
Throughout my Postgraduate training, I have been engaged in a wide range of clinical research projects, including two main projects: the ”Contribution of Genetic Polymorphisms of Vascular Endothelial Growth Factor to Bronchopulmonary Dysplasia” and the “Regulation of Renin-Angiotensin Systems in the Monochorionic Twin Pregnancies Complicated by Twin-to-Twin Transfusion Syndromes”. During my fellowship at Stanford, my research focus was to understand the function of heme oxygenase (HO), the rate-limiting enzyme in bilirubin production, and its contribution to neonatal diseases, specifically neonatal hyperbilirubinemia and sepsis, using animal models. I currently serve as an Associate Professor of Pediatrics at Kobe University Graduate School of Medicine as well as Chief of Neonatology at Kobe University Hospital.
Liang Gao
Dr. Liang Gao currently works as a senior Research Fellow at the Center of Experimental Orthopaedics, Saarland University, Germany. His clinical interests include sports medicine, arthroplasty, and traumatology. His research focuses on joint preservation and orthobiologics.
Dr. Gao studied Medicine in China and Germany with intensive fellowship training in both Asia and Europe. He completed the Musculoskeletal Surgical Oncology residency training at Peking University Medical Center, China. Moreover, he obtained his master of science degree (Radiation Oncology) from Heidelberg University, Germany and his doctorate (Biological Therapy) summa cum laude from Saarland University, Germany.
Dr. Gao is the Member of the Basic Science Committee of International Cartilage Regeneration & Joint Preservation Society (ICRS), the Member of the Early Career Investigator Committee of Osteoarthritis Research Society International (OARSI), and the Founding Member of the Sino Euro Orthopaedics Society (SEOS).
Gregory E. Gilbert
Currently Dr. Gilbert works for ICON plc, one of the leading CROs in the world, as a Senior Statistical Analyst. He has over 25 years of research and statistical programming experience. Before joining ICON, Greg supported 2 medical schools, a nursing school, & a vet school doing educational & clinical research. Greg is an accredited statistician by the American Statistical Association. In his position he leads development of statistical analysis plans, executes programming deliverables on multiple projects, and applies standard programming methods using SAS® for complex data reporting tasks. He communicates deliverable results with clients participating in the development of abstracts, presentations, and manuscripts. In addition to working at ICON plc, Dr. Gilbert is a biostatistician at SigmaStats Consulting, LLC a firm specializing in assisting doctoral students in completing their research or projects. Greg has co-authored over 80 peer-reviewed publications and 4 book chapters. He has experience with complex statistical methodologies including survival analysis (Kaplan Meier and proportional hazard), linear regression, mixed model regression, reproducible results, G theory, psychometrics, and R. Prior to receiving his EdD, Greg received a MSPH in Biostatistics and Epidemiology from the Univ of South Carolina (1991) and a BA in Psychology from Baylor (1987). He currently resides in Charleston, SC USA with his wife of over 30 years and 2 basset hounds.
Nikolaos Gkantidis
Nikolaos Gkantidis has been a full-time Senior Staff Member at the Department of Orthodontics and Dentofacial Orthopedics, University of Bern, Switzerland, since 2016. He earned the Venia Docendi (Privatdozent) title from the same institution in 2018 and the Assoc. Prof. title in 2024. Prof. Gkantidis graduated from the Dental School of the Aristotle University of Thessaloniki, Greece (2006). Subsequently, he pursued a post-graduate program in Orthodontics at the University of Athens, graduating with honours (2010), and run an orthodontic practice in Thessaloniki (2010-2016). Prof. Gkantidis completed his doctoral studies in Bern (2013) and also served as a part-time staff member of the Department (2012-2016). In 2022, he obtained a Ph.D. degree from the University of Groningen, the Netherlands.
Prof. Gkantidis has published numerous original research papers and forged national and international collaborations in key research areas, which include the development and utilization of 3D imaging techniques in clinical research and practice, the study of facial attractiveness, and the investigation of craniofacial form. For his innovative work he has received various national and international grants and awards.
Shawn M Gomez
Professor and Associate Chair for Research in the Joint Department of Biomedical Engineering at UNC-CH and NCSU and Professor in the Department of Pharmacology at UNC-CH. Previous Florence Gould Scholar and Pasteur Foundation Fellow. Current research interests in systems and synthetic biology, bioimage informatics, and network science applied to biology. Broader interests in translational medicine and the fostering of innovative solutions to problems in healthcare.
Fanglin Guan
Prof. Fanglin Guan is Dean at Xi'an Jiaotong University. He is engaged in the integrated biological research of complex diseases, including tumor microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumor cell vaccines, especially for the exploration of the mechanism of determining the biomarkers of complex diseases.